In the first half of 2024, Novo Nordisk's net sales were 133.409 billion Danish kroner, a year-on-year increase of 24%; net income was 45.457 billion Danish kroner, a year-on-year increase of 16%.
诺和诺德2024年上半年净利润454.57亿丹麦克朗，同比增长16%
Novo Nordisk's net income for the first half of 2024 was 45.457 billion Danish Kroner, with a year-on-year growth of 16%.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.